Phase IV Evaluation of the Adrenal Suppression Potential and PKPD of Halobetasol Propionate Foam, 0.05% in Adolescent Subjects with Plaque Psoriasis. (2021). SKIN The Journal of Cutaneous Medicine, 5(6), s47. https://doi.org/10.25251/skin.5.supp.47